BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 31, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Appointments and advancements for Nov. 17, 2025

Nov. 17, 2025
New hires and promotions in the med-tech industry, including: Micro Medical Solutions, Onco Nano, Seastar Medical, Tecan Group.
Read More

Financings for Nov. 17, 2025

Nov. 17, 2025
Med-tech firms raising money in public or private financings, including: Veri Medtech.
Read More

In the clinic for Nov. 17, 2025

Nov. 17, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ocean Dx.
Read More

Other news to note for Nov. 17, 2025

Nov. 17, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apple, Brainsway, Caranx, Cardiovalve, GE Healthcare, GTCR, ITM, Labcorp, Lunit, Masimo, Naveris, Positron, Surmodics, Venus Medtech.
Read More

Regulatory actions for Nov. 17, 2025

Nov. 17, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Onward Medical.
Read More

Med-tech gainers and losers for Nov. 10-14, 2025

Nov. 17, 2025
The top 10 med-tech stock gainers and losers for the week.
Read More
Withings Beamo multi-sensor device

FDA clears Withings Beamo, ‘thermometer of the future’

Nov. 14, 2025
By Shani Alexander
Withings SA received U.S. FDA clearance for Beamo, its health check-up tool designed to monitor heart and lung function. Described as the ‘thermometer of the future’, Beamo combines the sensors of an electrocardiogram, a stethoscope and a thermometer into a hand-held device to allow users to check their body temperature, cardiac and pulmonary health in less than a minute.
Read More
Cornerstone Robotics Sentire Surgical System

China’s Cornerstone Robotics raises $200M series D round

Nov. 14, 2025
By Tamra Sami
Cornerstone Robotics Ltd. raised an oversubscribed $200 million series D round to accelerate commercialization of its flagship product, the Sentire Endoscopic Surgical System.
Read More
U.S. EPA building

EPA eases up on PFAS reporting requirements

Nov. 14, 2025
By Mark McCarty
The U.S. Environmental Protection Agency has moved to relax reporting requirements for perfluoroalkyl and polyfluoroalkyl substances used in a variety of applications, including medical devices.
Read More

Appointments and advancements for Nov. 14, 2025

Nov. 14, 2025
New hires and promotions in the med-tech industry, including: Nanalysis Scientific, Sensus Healthcare.
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 … 10249 10250 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • U.S. Capitol building

    BMS-Hengrui deal strikes panic in Washington

    BioWorld
    On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
  • Medicine spilling onto map of Europe

    Initial data hint that US MFN pricing is hitting access in Europe

    BioWorld
    There are initial signs that President Donald Trump’s most-favored nation (MFN) policy may be further delaying access to new drugs in Europe, as companies hold...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing